Unraveling the Link between Periodontitis and Inflammatory Bowel Disease: Challenges and Outlook

Periodontitis and Inflammatory Bowel Disease (IBD) are chronic inflammatory conditions, characterized by microbial dysbiosis and hyper-immunoinflammatory responses. Growing evidence suggest an interconnection between periodontitis and IBD, implying a shift from the traditional concept of independent diseases to a complex, reciprocal cycle. This review outlines the evidence supporting an Oral-Gut axis, marked by a higher prevalence of periodontitis in IBD patients and vice versa. The specific mechanisms linking periodontitis and IBD remain to be fully elucidated, but emerging evidence points to the ectopic colonization of the gut by oral bacteria, which promote intestinal inflammation by activating host immune responses. This review presents an in-depth examination of the interconnection between periodontitis and IBD, highlighting the shared microbiological and immunological pathways, and proposing a multi-hit hypothesis in the pathogenesis of periodontitis-mediated intestinal inflammation. Furthermore, the review underscores the critical need for a collaborative approach between dentists and gastroenterologists to provide holistic oral-systemic healthcare.

[1]  K. Ozato,et al.  Mouse Homolog of Human IRF8G388S Mutation Provides Novel Insight into Osteoclastogenesis and Tooth Root Resorption , 2023, bioRxiv.

[2]  H. Tettelin,et al.  Periodontal disease is associated with increased gut colonization of pathogenic Haemophilus parainfluenzae in patients with Crohn’s disease , 2023, Cell reports.

[3]  Zhengmei Lin,et al.  Exploration of the shared gene signatures and molecular mechanisms between periodontitis and inflammatory bowel disease: evidence from transcriptome data , 2022, Gastroenterology report.

[4]  Xueyang Zhang,et al.  Periodontitis-induced oral microbiome alterations provide clues on how periodontitis exacerbates colitis. , 2022, Journal of Clinical Periodontology.

[5]  Shuo Zhang,et al.  The impact of aging on intestinal mucosal immune function and clinical applications , 2022, Frontiers in Immunology.

[6]  A. Gustafsson,et al.  Colitis induced by dextran sulphate sodium causes histopathological and immunological changes in the periodontal tissues of Wistar rats. , 2022, Journal of periodontal research.

[7]  F. Romano,et al.  Periodontitis Prevalence and Severity in Inflammatory Bowel Disease: A Case-Control Study. , 2022, Journal of periodontology.

[8]  Xiaoyue Zhang,et al.  Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism. , 2022, Journal of periodontology.

[9]  N. Pandis,et al.  Periodontitis prevalence in patients with ulcerative colitis and Crohn's disease ‐ PPCC: A case–control study , 2022, Journal of clinical periodontology.

[10]  G. Heo,et al.  Inflammatory bowel disease and periodontitis: A retrospective chart analysis , 2022, Clinical and experimental dental research.

[11]  Yan Xu,et al.  The oral microbiome analysis reveals the similarities and differences between periodontitis and Crohn's disease-associated periodontitis. , 2022, FEMS Microbiology Letters.

[12]  M. Toruner,et al.  Evaluation of periodontal status and cytokine levels in saliva and gingival crevicular fluid of patients with inflammatory bowel diseases , 2022, Journal of periodontology.

[13]  V. Murthy,et al.  Oral Health for All - Realizing the Promise of Science. , 2022, The New England journal of medicine.

[14]  E. Kenigsberg,et al.  Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity , 2022, Nature Medicine.

[15]  Chi-Jung Huang,et al.  The Periodontopathic Pathogen, Porphyromonas gingivalis, Involves a Gut Inflammatory Response and Exacerbates Inflammatory Bowel Disease , 2022, Pathogens.

[16]  Yijun Sun,et al.  Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9-producing CD4+ T cells. , 2021, Molecular oral microbiology.

[17]  A. Surdacka,et al.  Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease. , 2021, Life.

[18]  Yong Zhang,et al.  Exosomes derived from 3D-cultured MSCs improve therapeutic effects in periodontitis and experimental colitis and restore the Th17 cell/Treg balance in inflamed periodontium , 2021, International journal of oral science.

[19]  Y. Huang,et al.  Periodontitis Salivary Microbiota Worsens Colitis , 2021, Journal of dental research.

[20]  Kyle J. Gaulton,et al.  A single-cell atlas of chromatin accessibility in the human genome , 2021, Cell.

[21]  W. Giannobile,et al.  A potential pathogenic association between periodontal disease and Crohn’s disease , 2021, JCI insight.

[22]  Vineet K. Sharma,et al.  Western and non-western gut microbiomes reveal new roles of Prevotella in carbohydrate metabolism and mouth–gut axis , 2021, npj Biofilms and Microbiomes.

[23]  F. Romano,et al.  Periodontitis and Accelerated Biological Aging: A Geroscience Approach , 2021, Journal of dental research.

[24]  Ze Lu,et al.  Porphyromonas gingivalis exacerbates ulcerative colitis via Porphyromonas gingivalis peptidylarginine deiminase , 2021, International journal of oral science.

[25]  M. Curtis,et al.  The role of oral bacteria in inflammatory bowel disease , 2021, Nature Reviews Gastroenterology & Hepatology.

[26]  Jacob M. Allen,et al.  Psychological stress disrupts intestinal epithelial cell function and mucosal integrity through microbe and host-directed processes , 2021, bioRxiv.

[27]  H. Tilg,et al.  Calprotectin: from biomarker to biological function , 2021, Gut.

[28]  C. Reilly,et al.  Calprotectin (S100A8/A9) Is an Innate Immune Effector in Experimental Periodontitis , 2021, Infection and immunity.

[29]  J. Colombel,et al.  Aging and IBD: A New Challenge for Clinicians and Researchers. , 2021, Inflammatory bowel diseases.

[30]  G. Zeng,et al.  Porphyromonas gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome , 2021, Cancer Research.

[31]  Ajay S. Gulati,et al.  The “Gum–Gut” Axis in Inflammatory Bowel Diseases: A Hypothesis-Driven Review of Associations and Advances , 2021, Frontiers in Immunology.

[32]  N. Buduneli,et al.  Shared microbiological and immunological patterns in periodontitis and IBD: A scoping review , 2021, Oral diseases.

[33]  K. Katakura,et al.  Ingestion of Porphyromonas gingivalis exacerbates colitis via intestinal epithelial barrier disruption in mice. , 2021, Journal of periodontal research.

[34]  G. Hajishengallis,et al.  Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities , 2021, Nature Reviews Immunology.

[35]  M. Somerman,et al.  Multiple Idiopathic Cervical Root Resorption: A Challenge for a Transdisciplinary Medical-Dental Team , 2021, Frontiers in Dental Medicine.

[36]  H. Fan,et al.  IRF/Type I IFN signaling serves as a valuable therapeutic target in the pathogenesis of inflammatory bowel disease. , 2021, International immunopharmacology.

[37]  C. M. Figueredo,et al.  Higher salivary expression of S100A12 in patients with ulcerative colitis and chronic periodontitis. , 2021, European journal of gastroenterology & hepatology.

[38]  A. Lorenzo-Pouso,et al.  Association between periodontal disease and inflammatory bowel disease: a systematic review and meta-analysis , 2020, Acta odontologica Scandinavica.

[39]  Zhenhua Luo,et al.  Porphyromonas gingivalis and Lactobacillus rhamnosus GG regulate the Th17/Treg balance in colitis via TLR4 and TLR2 , 2020, Clinical & translational immunology.

[40]  D. Manuel,et al.  Life expectancy and health-adjusted life expectancy in people with inflammatory bowel disease , 2020, Canadian Medical Association Journal.

[41]  M. Somerman,et al.  Integrating Oral and Systemic Health: Innovations in Transdisciplinary Science, Health Care and Policy , 2020, Frontiers in Dental Medicine.

[42]  O. Mandelboim,et al.  Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System , 2020, Frontiers in Cellular and Infection Microbiology.

[43]  W. Shi,et al.  Acquisition and Adaptation of Ultra-small Parasitic Reduced Genome Bacteria to Mammalian Hosts , 2020, Cell reports.

[44]  W. Giannobile,et al.  The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis , 2020, Cell.

[45]  P. Diaz,et al.  The role of the microbiota in periodontal disease. , 2020, Periodontology 2000.

[46]  M. Nazir,et al.  Global Prevalence of Periodontal Disease and Lack of Its Surveillance , 2020, TheScientificWorldJournal.

[47]  T. Schmidt,et al.  The Bacterial Connection between the Oral Cavity and the Gut Diseases , 2020, Journal of dental research.

[48]  H. Xiong,et al.  Fusobacterium nucleatum exacerbates colitis by damaging epithelial barriers and inducing aberrant inflammation , 2020, Journal of digestive diseases.

[49]  S. Mazzacane,et al.  Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture , 2020, BMC Microbiology.

[50]  I. Chapple,et al.  Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline , 2020, Journal of clinical periodontology.

[51]  M. Nagasaki,et al.  Genetic Analysis of Ulcerative Colitis in Japanese Individuals Using Population-specific SNP Array. , 2020, Inflammatory bowel diseases.

[52]  Xiang Gao,et al.  Increased risks of dental caries and periodontal disease in Chinese patients with inflammatory bowel disease. , 2020, International dental journal.

[53]  R. Genco,et al.  The Periodontal Microenvironment: a Potential Reservoir for Intestinal Pathobionts in Crohn’s Disease , 2020, Current Oral Health Reports.

[54]  E. Quigley,et al.  The microbiome and inflammatory bowel disease. , 2020, The Journal of allergy and clinical immunology.

[55]  D. Zawieja,et al.  DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone , 2019, Scientific Reports.

[56]  T. H. Nguyen,et al.  The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The lancet. Gastroenterology & hepatology.

[57]  F. Bucchieri,et al.  Probiotics Can Cure Oral Aphthous-Like Ulcers in Inflammatory Bowel Disease Patients: A Review of the Literature and a Working Hypothesis , 2019, International journal of molecular sciences.

[58]  M. Parkes,et al.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults , 2019, Gut.

[59]  F. Carinci,et al.  Prevalence of Oral Lesions and Correlation with Intestinal Symptoms of Inflammatory Bowel Disease: A Systematic Review , 2019, Diagnostics.

[60]  J. Raes,et al.  Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses , 2019, Nature Microbiology.

[61]  Liping Liang,et al.  Fusobacterium nucleatum Aggravates the Progression of Colitis by Regulating M1 Macrophage Polarization via AKT2 Pathway , 2019, Front. Immunol..

[62]  K. Ozato,et al.  Inactivating Mutation in IRF8 Promotes Osteoclast Transcriptional Programs and Increases Susceptibility to Tooth Root Resorption , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[63]  Xinxiang Li,et al.  Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer , 2019, Theranostics.

[64]  M. Neurath,et al.  Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances , 2019, Gut.

[65]  Kevin S. Bonham,et al.  Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases , 2019, Nature.

[66]  Y. Jeen,et al.  Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients , 2019, Cells.

[67]  S. Seyedian,et al.  A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease , 2019, Journal of medicine and life.

[68]  G. Rossi‐Fedele,et al.  Interaction of biologic therapy with apical periodontitis and periodontitis: a systematic review. , 2019, Australian dental journal.

[69]  W. Shi,et al.  Saccharibacteria (TM7) in the Human Oral Microbiome , 2019, Journal of dental research.

[70]  P. de Vos,et al.  Age-associated Impairment of the Mucus Barrier Function is Associated with Profound Changes in Microbiota and Immunity , 2019, Scientific Reports.

[71]  D. Ojcius,et al.  Association between periodontal pathogens and systemic disease , 2019, Biomedical journal.

[72]  Sammed N. Mandape,et al.  Identification of Specific Oral and Gut Pathogens in Full Thickness Colon of Colitis Patients: Implications for Colon Motility , 2019, Front. Microbiol..

[73]  W. Harmsen,et al.  Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010 , 2019, Therapeutic advances in gastroenterology.

[74]  Chen-feng Qi,et al.  T follicular helper cells restricted by IRF8 contribute to T cell-mediated inflammation. , 2019, Journal of autoimmunity.

[75]  Luis Pedro Coelho,et al.  Extensive transmission of microbes along the gastrointestinal tract , 2018, bioRxiv.

[76]  P. Buckhaults,et al.  Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis , 2018, Cell reports.

[77]  J. Maul,et al.  The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy , 2018, Journal of Crohn's & colitis.

[78]  P. Usai,et al.  Healing of Apical Periodontitis in Patients with Inflammatory Bowel Diseases and under Anti–tumor Necrosis Factor Alpha Therapy , 2018, Journal of endodontics.

[79]  R. Lamont,et al.  The oral microbiota: dynamic communities and host interactions , 2018, Nature Reviews Microbiology.

[80]  P. Dorrestein,et al.  Identification of the Bacterial Biosynthetic Gene Clusters of the Oral Microbiome Illuminates the Unexplored Social Language of Bacteria during Health and Disease , 2018, mBio.

[81]  C. Huttenhower,et al.  Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course. , 2018, Cell host & microbe.

[82]  L. Ding,et al.  Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing &agr;‐ketoglutarate production in mice , 2018, Molecular oral microbiology.

[83]  C. Bai,et al.  Increased risk of periodontitis among patients with Crohn’s disease: a population-based matched-cohort study , 2018, International Journal of Colorectal Disease.

[84]  A. Nakajima,et al.  Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity , 2018, Gut.

[85]  F. Dewhirst,et al.  New Insights into Human Nostril Microbiome from the Expanded Human Oral Microbiome Database (eHOMD): a Resource for the Microbiome of the Human Aerodigestive Tract , 2018, mSystems.

[86]  R. Haak,et al.  Active matrix metalloproteinase‐8 and periodontal bacteria—interlink between periodontitis and inflammatory bowel disease? , 2018, Journal of periodontology.

[87]  Z. Xun,et al.  Dysbiosis and Ecotypes of the Salivary Microbiome Associated With Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles , 2018, Front. Microbiol..

[88]  W. Turpin,et al.  Determinants of IBD Heritability: Genes, Bugs, and More. , 2018, Inflammatory bowel diseases.

[89]  C. Elson,et al.  Adaptive immune education by gut microbiota antigens , 2018, Immunology.

[90]  Feng Chen,et al.  Oral microbiomes: more and more importance in oral cavity and whole body , 2018, Protein & Cell.

[91]  Yu-Chao Chang,et al.  Inflammatory bowel disease as a risk factor for periodontitis under Taiwanese National Health Insurance Research database , 2018, Journal of dental sciences.

[92]  H. Takayanagi,et al.  Host defense against oral microbiota by bone-damaging T cells , 2018, Nature Communications.

[93]  S. Bueno,et al.  Impact of Cigarette Smoking on the Gastrointestinal Tract Inflammation: Opposing Effects in Crohn’s Disease and Ulcerative Colitis , 2018, Front. Immunol..

[94]  Nima Hamidi,et al.  Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies , 2017, The Lancet.

[95]  M. Neurath,et al.  Current and emerging therapeutic targets for IBD , 2017, Nature Reviews Gastroenterology & Hepatology.

[96]  J. Torres,et al.  Familial and ethnic risk in inflammatory bowel disease , 2017, Annals of gastroenterology.

[97]  J. Segre,et al.  Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation , 2017, Science.

[98]  F. Shanahan,et al.  The oral microbiota in colorectal cancer is distinctive and predictive , 2017, Gut.

[99]  G. Rogler,et al.  Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment , 2017, Journal of pediatric gastroenterology and nutrition.

[100]  Rongling Wu,et al.  Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease , 2017, World journal of gastroenterology.

[101]  T. Buford (Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease , 2017, Microbiome.

[102]  Dale Lee,et al.  Oral manifestations as the first presenting sign of Crohn’s disease in a pediatric patient , 2017, Journal of clinical and experimental dentistry.

[103]  A. Gustafsson,et al.  Activity of inflammatory bowel disease influences the expression of cytokines in gingival tissue , 2017, Cytokine.

[104]  Hailiang Huang,et al.  Fine-mapping inflammatory bowel disease loci to single variant resolution , 2017, Nature.

[105]  Stefan Wirtz,et al.  Chemically induced mouse models of acute and chronic intestinal inflammation , 2017, Nature Protocols.

[106]  C. Langner,et al.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. , 2017, Journal of Crohn's & colitis.

[107]  J. Potempa,et al.  Manipulation of Neutrophils by Porphyromonas gingivalis in the Development of Periodontitis , 2017, Front. Cell. Infect. Microbiol..

[108]  N. Juge,et al.  Introduction to the human gut microbiota , 2017, The Biochemical journal.

[109]  K. Takeda,et al.  Roles of intestinal epithelial cells in the maintenance of gut homeostasis , 2017, Experimental &Molecular Medicine.

[110]  I. Thiele,et al.  Gut microbiota functions: metabolism of nutrients and other food components , 2017, European Journal of Nutrition.

[111]  C. Buskens,et al.  3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations. , 2017, Journal of Crohn's & colitis.

[112]  Harry Sokol,et al.  A microbial signature for Crohn's disease , 2017, Gut.

[113]  G. Bouma,et al.  Gastrointestinal diseases and their oro-dental manifestations: Part 1: Crohn's disease , 2016, BDJ.

[114]  C. Oury,et al.  The Dual Role of Neutrophils in Inflammatory Bowel Diseases , 2016, Journal of clinical medicine.

[115]  B. Chassaing,et al.  When pathogenic bacteria meet the intestinal microbiota , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.

[116]  P. Eke,et al.  Periodontitis prevalence in adults ≥ 65 years of age, in the USA. , 2016, Periodontology 2000.

[117]  C. M. Figueredo,et al.  Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions? , 2016, World journal of gastroenterology.

[118]  Gunnar C. Hansson,et al.  Immunological aspects of intestinal mucus and mucins , 2016, Nature Reviews Immunology.

[119]  M. Muhvić-Urek,et al.  Oral pathology in inflammatory bowel disease. , 2016, World journal of gastroenterology.

[120]  D. McGovern,et al.  Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility , 2016, Expert review of clinical immunology.

[121]  David C. Wilson,et al.  Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease , 2016, Nature Genetics.

[122]  Weidong Tian,et al.  Explaining the disease phenotype of intergenic SNP through predicted long range regulation , 2016, Nucleic acids research.

[123]  K. Kirkwood,et al.  Aggregatibacter actinomycetemcomitans, a potent immunoregulator of the periodontal host defense system and alveolar bone homeostasis. , 2016, Molecular oral microbiology.

[124]  C. M. Figueredo,et al.  Cytokine expression in gingival and intestinal tissues of patients with periodontitis and inflammatory bowel disease: An exploratory study. , 2016, Archives of oral biology.

[125]  H. Nielsen,et al.  Optimized cultivation of Campylobacter concisus from gut mucosal biopsies in inflammatory bowel disease , 2016, Gut Pathogens.

[126]  Morris A. Swertz,et al.  Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity , 2016, Science.

[127]  F. Ryan,et al.  Tumour-associated and non-tumour-associated microbiota in colorectal cancer , 2016, Gut.

[128]  H. Tilg,et al.  The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. , 2016, Journal of Crohn's & colitis.

[129]  W. Leonard,et al.  Cutting Edge: Expression of IRF8 in Gastric Epithelial Cells Confers Protective Innate Immunity against Helicobacter pylori Infection , 2016, The Journal of Immunology.

[130]  A. Margolles,et al.  Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health , 2016, Front. Microbiol..

[131]  J. Limdi,et al.  Elderly patients and inflammatory bowel disease. , 2016, World journal of gastrointestinal pharmacology and therapeutics.

[132]  D. Aronoff,et al.  The influence of non-steroidal anti-inflammatory drugs on the gut microbiome. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[133]  R. Milo,et al.  Revised Estimates for the Number of Human and Bacteria Cells in the Body , 2016, bioRxiv.

[134]  Jingyuan Fu,et al.  Proton pump inhibitors affect the gut microbiome , 2015, Gut.

[135]  A. Kühl,et al.  Diversity of Intestinal Macrophages in Inflammatory Bowel Diseases , 2015, Front. Immunol..

[136]  G. Kaplan,et al.  The global burden of IBD: from 2015 to 2025 , 2015, Nature Reviews Gastroenterology &Hepatology.

[137]  F. Bushman,et al.  Alterations of the Subgingival Microbiota in Pediatric Crohn's Disease Studied Longitudinally in Discovery and Validation Cohorts , 2015, Inflammatory bowel diseases.

[138]  C. Romano,et al.  Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis , 2015, Front. Immunol..

[139]  R. D'Incà,et al.  Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut , 2015, Mediators of inflammation.

[140]  Nora C. Toussaint,et al.  Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial. , 2015, Gastroenterology.

[141]  John D Lambris,et al.  Neutrophil homeostasis and inflammation: novel paradigms from studying periodontitis , 2015, Journal of leukocyte biology.

[142]  A. Zellos,et al.  Dental Caries and Periodontal Disease in Children and Adolescents with Inflammatory Bowel Disease: A Case–Control Study , 2015, Inflammatory bowel diseases.

[143]  M. Fain,et al.  Inflammatory bowel disease and the elderly: a review. , 2015, Journal of Crohn's & colitis.

[144]  P. Eke,et al.  Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012. , 2015, Journal of periodontology.

[145]  R. Baldassano,et al.  Diet in the pathogenesis and treatment of inflammatory bowel diseases. , 2015, Gastroenterology.

[146]  N. Akseer,et al.  Oral microbiome composition changes in mouse models of colitis , 2015, Journal of gastroenterology and hepatology.

[147]  R. Lamont,et al.  Polymicrobial synergy and dysbiosis in inflammatory disease. , 2015, Trends in molecular medicine.

[148]  W. Strober,et al.  Experimental Models of Inflammatory Bowel Diseases , 2015, Cellular and molecular gastroenterology and hepatology.

[149]  G. Hajishengallis,et al.  Periodontitis: from microbial immune subversion to systemic inflammation , 2014, Nature Reviews Immunology.

[150]  S. Yooseph,et al.  Cultivation of a human-associated TM7 phylotype reveals a reduced genome and epibiotic parasitic lifestyle , 2014, Proceedings of the National Academy of Sciences.

[151]  P. Vernia,et al.  Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. , 2014, World journal of gastroenterology.

[152]  K. Kinzler,et al.  Microbiota organization is a distinct feature of proximal colorectal cancers , 2014, Proceedings of the National Academy of Sciences.

[153]  F. Turroni,et al.  Intestinal Dysbiosis Associated with Systemic Lupus Erythematosus , 2014, mBio.

[154]  A. Arsenijević,et al.  Potential Dual Immunomodulatory Role of VEGF in Ulcerative Colitis and Colorectal Carcinoma , 2014, International journal of medical sciences.

[155]  Sjoerd Post,et al.  The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system , 2014, Immunological reviews.

[156]  H. Al‐Salami,et al.  Inflammatory bowel disease: clinical aspects and treatments , 2014, Journal of inflammation research.

[157]  J. Round,et al.  Defining dysbiosis and its influence on host immunity and disease , 2014, Cellular microbiology.

[158]  D. Motooka,et al.  Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota , 2014, Scientific Reports.

[159]  Xiaofei Xu,et al.  Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization , 2014, Cellular and Molecular Immunology.

[160]  S. Mitra,et al.  Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. , 2014, Physiological reviews.

[161]  Y. Belkaid,et al.  Role of the Microbiota in Immunity and Inflammation , 2014, Cell.

[162]  S. Holland,et al.  Defective Neutrophil Recruitment in Leukocyte Adhesion Deficiency Type I Disease Causes Local IL-17–Driven Inflammatory Bone Loss , 2014, Science Translational Medicine.

[163]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[164]  B. Paster,et al.  Differences in bacterial saliva profile between periodontitis patients and a control cohort. , 2014, Journal of clinical periodontology.

[165]  B. Chassaing,et al.  Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice , 2014, Current protocols in immunology.

[166]  J. Goedert,et al.  Human gut microbiome and risk for colorectal cancer. , 2013, Journal of the National Cancer Institute.

[167]  K. Lankarani,et al.  Oral manifestation in inflammatory bowel disease: a review. , 2013, World journal of gastroenterology.

[168]  T. Attin,et al.  Periodontitis and Gingivitis in Inflammatory Bowel Disease: A Case–Control Study , 2013, Inflammatory bowel diseases.

[169]  G. Petris,et al.  European consensus on the histopathology of inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.

[170]  M. Icaza-Chávez,et al.  [Gut microbiota in health and disease]. , 2013, Revista de Gastroenterología de México.

[171]  Dan Knights,et al.  Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome , 2013, Gut.

[172]  Taeko Dohi,et al.  Dysbiosis of Salivary Microbiota in Inflammatory Bowel Disease and Its Association With Oral Immunological Biomarkers , 2013, DNA research : an international journal for rapid publication of reports on genes and genomes.

[173]  R. D. De Lisle,et al.  The cystic fibrosis intestine. , 2013, Cold Spring Harbor perspectives in medicine.

[174]  T. Yucel-Lindberg,et al.  Inflammatory mediators in the pathogenesis of periodontitis , 2013, Expert Reviews in Molecular Medicine.

[175]  Gabriel Núñez,et al.  Control of pathogens and pathobionts by the gut microbiota , 2013, Nature Immunology.

[176]  W. Borgnakke,et al.  Risk factors for periodontal disease. , 2013, Periodontology 2000.

[177]  N. Pedersen,et al.  East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort , 2013, Gut.

[178]  H. Shin,et al.  Genome-Wide Association Study of Ulcerative Colitis in Koreans Suggests Extensive Overlapping of Genetic Susceptibility With Caucasians , 2013, Inflammatory bowel diseases.

[179]  M. Johansson,et al.  The gastrointestinal mucus system in health and disease , 2013, Nature Reviews Gastroenterology &Hepatology.

[180]  W. Wade,et al.  The oral microbiome in health and disease. , 2013, Pharmacological research.

[181]  B. Hartmann,et al.  Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. , 2013, The Journal of allergy and clinical immunology.

[182]  L. Dauchet,et al.  Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study , 2013, Gut.

[183]  A. Gustafsson,et al.  Subgingival microflora in inflammatory bowel disease patients with untreated periodontitis , 2013, European journal of gastroenterology & hepatology.

[184]  D. Swallow,et al.  Refinement in localization and identification of gene regions associated with Crohn disease. , 2013, American journal of human genetics.

[185]  R. Lamont,et al.  Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. , 2012, Molecular oral microbiology.

[186]  S. Wahl,et al.  Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. , 2012, Journal of autoimmunity.

[187]  Casey T. Weaver,et al.  Reciprocal interactions of the intestinal microbiota and immune system , 2012, Nature.

[188]  V. Tremaroli,et al.  Functional interactions between the gut microbiota and host metabolism , 2012, Nature.

[189]  G. Hajishengallis,et al.  The keystone-pathogen hypothesis , 2012, Nature Reviews Microbiology.

[190]  Y. Khader,et al.  The association between inflammatory bowel disease and periodontitis among Jordanians: a case-control study. , 2012, Journal of periodontal research.

[191]  S. Riordan,et al.  Investigation of the Enteric Pathogenic Potential of Oral Campylobacter concisus Strains Isolated from Patients with Inflammatory Bowel Disease , 2012, PloS one.

[192]  Yaoyu E. Wang,et al.  Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease , 2012, Inflammatory bowel diseases.

[193]  Ashu Sharma,et al.  Fusobacterium nucleatum and Tannerella forsythia Induce Synergistic Alveolar Bone Loss in a Mouse Periodontitis Model , 2012, Infection and Immunity.

[194]  C. Parkos,et al.  The role of neutrophils during intestinal inflammation , 2012, Mucosal Immunology.

[195]  Richard A. Moore,et al.  Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.

[196]  Hsin-Jung Wu,et al.  The role of gut microbiota in immune homeostasis and autoimmunity , 2012, Gut microbes.

[197]  D. Swallow,et al.  Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn disease. , 2011, American journal of human genetics.

[198]  Raphael Zidovetzki,et al.  A Comprehensive Analysis of Shared Loci between Systemic Lupus Erythematosus (SLE) and Sixteen Autoimmune Diseases Reveals Limited Genetic Overlap , 2011, PLoS genetics.

[199]  John D Lambris,et al.  Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. , 2011, Cell host & microbe.

[200]  C. Zenobia,et al.  The relationship of the oral microbiotia to periodontal health and disease. , 2011, Cell host & microbe.

[201]  Tarah Lynch,et al.  Invasive potential of gut mucosa‐derived fusobacterium nucleatum positively correlates with IBD status of the host , 2011, Inflammatory bowel diseases.

[202]  Qingshan Li,et al.  Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation , 2011, Nature communications.

[203]  C. Lees,et al.  Guidelines for the management of inflammatory bowel disease in adults , 2011, Gut.

[204]  A. Gustafsson,et al.  Expression of cytokines in the gingival crevicular fluid and serum from patients with inflammatory bowel disease and untreated chronic periodontitis. , 2011, Journal of periodontal research.

[205]  Ashu Sharma Virulence mechanisms of Tannerella forsythia. , 2010, Periodontology 2000.

[206]  Susan Kinder-Haake,et al.  Fusobacterium nucleatum Outer Membrane Proteins Fap2 and RadD Induce Cell Death in Human Lymphocytes , 2010, Infection and Immunity.

[207]  J. Ebersole,et al.  A Model for Chronic Mucosal Inflammation in IBD and Periodontitis , 2010, Digestive Diseases and Sciences.

[208]  J. Izard,et al.  The Human Oral Microbiome , 2010, Journal of bacteriology.

[209]  R. Darveau,et al.  Periodontitis: a polymicrobial disruption of host homeostasis , 2010, Nature Reviews Microbiology.

[210]  Si Ming Man,et al.  Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease , 2010, Inflammatory bowel diseases.

[211]  B. Finlay,et al.  Muc2 Protects against Lethal Infectious Colitis by Disassociating Pathogenic and Commensal Bacteria from the Colonic Mucosa , 2010, PLoS pathogens.

[212]  F. Lammert,et al.  Clinical periodontal and microbiologic parameters in patients with Crohn's disease with consideration of the CARD15 genotype. , 2010, Journal of periodontology.

[213]  Kathryn Roeder,et al.  Genome-wide association identifies multiple ulcerative colitis susceptibility loci , 2010, Nature Genetics.

[214]  A. Kornbluth,et al.  Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee , 2010, The American Journal of Gastroenterology.

[215]  D. Massi,et al.  Pyostomatitis Vegetans: Cellular Immune Profile and Expression of IL-6, IL-8 and TNF-α , 2010, Head and neck pathology.

[216]  J. Ebersole,et al.  A novel murine model for chronic inflammatory alveolar bone loss. , 2010, Journal of periodontal research.

[217]  A. Schäffer,et al.  Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.

[218]  A. Kantarcı,et al.  Hyperactivated B cells in human inflammatory bowel disease , 2009, Journal of leukocyte biology.

[219]  J Highfield,et al.  Diagnosis and classification of periodontal disease. , 2009, Australian dental journal.

[220]  Ludwig Kappos,et al.  Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.

[221]  M. Daly,et al.  Identifying Relationships among Genomic Disease Regions: Predicting Genes at Pathogenic SNP Associations and Rare Deletions , 2009, PLoS genetics.

[222]  S. Mazmanian,et al.  The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.

[223]  Kun Tang,et al.  Global diversity in the human salivary microbiome. , 2009, Genome research.

[224]  R. Kubilius,et al.  Lysozyme and microbiota in relation to gingivitis and periodontitis. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[225]  Y. Gabet,et al.  Dextran sodium sulfate-induced colitis causes rapid bone loss in mice. , 2008, Bone.

[226]  Judy H. Cho,et al.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.

[227]  A. Gustafsson,et al.  Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis. , 2008, Journal of clinical periodontology.

[228]  F. Hoentjen,et al.  Pathophysiology of Inflammatory Bowel Diseases , 2008 .

[229]  P. Lakatos,et al.  Smoking in inflammatory bowel diseases: good, bad or ugly? , 2007, World journal of gastroenterology.

[230]  Ken Kleinman,et al.  The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[231]  D. Cohen,et al.  Gingival involvement in Crohn disease. , 2007, Journal of the American Dental Association.

[232]  Vivien Kwok,et al.  Commentary: prognosis revisited: a system for assigning periodontal prognosis. , 2007, Journal of periodontology.

[233]  G. Seymour,et al.  Relationship between periodontal infections and systemic disease. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[234]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[235]  S. Carding,et al.  Inflammatory bowel disease: cause and immunobiology , 2007, The Lancet.

[236]  P. Mannon,et al.  The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.

[237]  D. Foell,et al.  S100 proteins expressed in phagocytes: a novel group of damage‐associated molecular pattern molecules , 2007, Journal of leukocyte biology.

[238]  S. Amar,et al.  Periodontal disease and systemic conditions: a bidirectional relationship , 2006, Odontology.

[239]  C. Hart,et al.  Bacterial killing in gastric juice--effect of pH and pepsin on Escherichia coli and Helicobacter pylori. , 2006, Journal of medical microbiology.

[240]  E. Stange,et al.  Extraintestinal manifestations and complications in inflammatory bowel diseases. , 2006, World journal of gastroenterology.

[241]  M. Cesta Normal Structure, Function, and Histology of Mucosa-Associated Lymphoid Tissue , 2006, Toxicologic pathology.

[242]  C. Cutler,et al.  Dendritic Cells at the Oral Mucosal Interface , 2006, Journal of dental research.

[243]  R. Sartor Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[244]  B. Größner-Schreiber,et al.  Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. , 2006, Journal of clinical periodontology.

[245]  D. Kinane,et al.  Environmental and other modifying factors of the periodontal diseases. , 2006, Periodontology 2000.

[246]  J. A. Aas,et al.  Defining the Normal Bacterial Flora of the Oral Cavity , 2005, Journal of Clinical Microbiology.

[247]  D. Kinane,et al.  Advances in the pathogenesis of periodontitis. Group B consensus report of the fifth European Workshop in Periodontology. , 2005, Journal of clinical periodontology.

[248]  E. Crushell,et al.  A prospective study of the oral manifestations of Crohn's disease. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[249]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[250]  S. Holt,et al.  Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the "red complex", a prototype polybacterial pathogenic consortium in periodontitis. , 2005, Periodontology 2000.

[251]  R. Baldassano,et al.  Extraintestinal manifestations of inflammatory bowel disease. , 2005, Minerva gastroenterologica e dietologica.

[252]  S. Socransky,et al.  Periodontal microbial ecology. , 2005, Periodontology 2000.

[253]  Ashu Sharma,et al.  Tannerella forsythia-induced Alveolar Bone Loss in Mice Involves Leucine-rich-repeat BspA Protein , 2005, Journal of dental research.

[254]  W. Walker,et al.  The role of gut-associated lymphoid tissues and mucosal defence , 2005, British Journal of Nutrition.

[255]  P. Petersen,et al.  Improving the oral health of older people: the approach of the WHO Global Oral Health Programme. , 2005, Community dentistry and oral epidemiology.

[256]  K. Bergh,et al.  Gastric juice: a barrier against infectious diseases. , 2005, Basic & clinical pharmacology & toxicology.

[257]  Hidde L Ploegh,et al.  CX3CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance , 2005, Science.

[258]  I. Brandslund,et al.  Saliva Interleukin-6 in patients with inflammatory bowel disease , 2005, Scandinavian journal of gastroenterology.

[259]  S. Travis,et al.  Guidelines for the management of inflammatory bowel disease in adults , 2004, Gut.

[260]  B. Pulendran,et al.  Human dendritic cells respond to Porphyromonas gingivalis LPS by promoting a Th2 effector response in vitro , 2003, European journal of immunology.

[261]  M. Kamm,et al.  The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria , 2003, Gut.

[262]  M. Neurath,et al.  Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. , 2003, The Journal of clinical investigation.

[263]  Julie S. Jurenka,et al.  Inflammatory bowel disease Part 1: ulcerative colitis--pathophysiology and conventional and alternative treatment options. , 2003, Alternative medicine review : a journal of clinical therapeutic.

[264]  Robert J. Palmer,et al.  Communication among Oral Bacteria , 2002, Microbiology and Molecular Biology Reviews.

[265]  H. Ogata,et al.  Animal models of inflammatory bowel disease , 2002, Journal of Gastroenterology.

[266]  Judy H. Cho,et al.  Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease , 2002, Clinical Microbiology Reviews.

[267]  F. Dewhirst,et al.  Bacterial Diversity in Human Subgingival Plaque , 2001, Journal of bacteriology.

[268]  P. Fleming,et al.  The oral cavity in Crohn's disease. , 2001, The Journal of pediatrics.

[269]  Shoichiro Tsukita,et al.  Multifunctional strands in tight junctions , 2001, Nature Reviews Molecular Cell Biology.

[270]  F. Shanahan,et al.  Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. , 2001, Gastroenterology.

[271]  S. Humphrey,et al.  A review of saliva: normal composition, flow, and function. , 2001, The Journal of prosthetic dentistry.

[272]  H. Jenkinson,et al.  Subgingival colonization by Porphyromonas gingivalis. , 2000, Oral microbiology and immunology.

[273]  R. Genco,et al.  Interactions between Periodontal Bacteria and Human Oral Epithelial Cells: Fusobacterium nucleatum Adheres to and Invades Epithelial Cells , 2000, Infection and Immunity.

[274]  A. Zinsmeister,et al.  Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival , 2000, Gut.

[275]  S. Pichyangkul,et al.  The immune modulation of B-cell responses by Porphyromonas ginginvalis and interleukin-10. , 2000, Journal of periodontology.

[276]  L. Kesavalu,et al.  Virulence factors of Porphyromonas gingivalis. , 1999, Periodontology 2000.

[277]  P. Fives-Taylor,et al.  Virulence factors of Actinobacillus actinomycetemcomitans. , 1999, Periodontology 2000.

[278]  R. Lamont,et al.  Life Below the Gum Line: Pathogenic Mechanisms ofPorphyromonas gingivalis , 1998, Microbiology and Molecular Biology Reviews.

[279]  R. Moots,et al.  Intestinal permeability and inflammation in patients on NSAIDs , 1998, Gut.

[280]  S. Cornain,et al.  Decreased CD4+/CD8+ ratio in major type of recurrent aphthous ulcers: comparing major to minor types of ulcers. , 1998, Asian Pacific journal of allergy and immunology.

[281]  A. Zinsmeister,et al.  Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. , 1998, Gastroenterology.

[282]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[283]  J. Terwilliger,et al.  Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12 , 1996, Nature Genetics.

[284]  F. T. Veloso,et al.  Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. , 1996, Journal of clinical gastroenterology.

[285]  B. Henderson,et al.  Virulence factors of Actinobacillus actinomycetemcomitans relevant to the pathogenesis of inflammatory periodontal diseases. , 1995, FEMS microbiology reviews.

[286]  P. Prior,et al.  Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. , 1994, Gut.

[287]  W. Wood,et al.  Pyodermatitis-pyostomatitis vegetans: a specific marker for inflammatory bowel disease. , 1994, Journal of the American Academy of Dermatology.

[288]  K. Das,et al.  A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody. , 1994, Gastroenterology.

[289]  P. Choi,et al.  Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. , 1994, Gut.

[290]  C. Lindqvist,et al.  Gingival and dental status, salivary acidogenic bacteria, and yeast counts of patients with active or inactive Crohn's disease. , 1994, Oral surgery, oral medicine, and oral pathology.

[291]  F. Shanahan,et al.  Prevalence and severity of periodontal disease in patients with inflammatory bowel disease. , 1991, Journal of clinical periodontology.

[292]  G. Hellers,et al.  Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease. , 1991, Scandinavian journal of gastroenterology.

[293]  S. Sakamaki,et al.  A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. , 1990, Gastroenterology.

[294]  J. Rotter,et al.  Geographic origins of Jewish patients with inflammatory bowel disease. , 1989, Gastroenterology.

[295]  P. Reichart,et al.  [Oral manifestations of Crohn's disease]. , 1988, Deutsche Zeitschrift fur Mund-, Kiefer- und Gesichts-Chirurgie.

[296]  S. Offenbacher,et al.  Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease , 1986, Infection and immunity.

[297]  J. Slots,et al.  Actinobacillus actinomycetemcomitans in human periodontal disease. Prevalence in patient groups and distribution of biotypes and serotypes within families. , 1983, Journal of periodontology.

[298]  S. Sonis,et al.  An analysis of peripheral blood and salivary polymorphonuclear leukocyte function, circulating immune complex levels and oral status in patients with inflammatory bowel disease. , 1982, Journal of periodontology.

[299]  R. Genco,et al.  Actinobacillus actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation. , 1980, Infection and immunity.

[300]  W. Bottomley,et al.  Oral extension of regional enteritis (Crohn's disease). Report of a case. , 1972, Oral surgery, oral medicine, and oral pathology.

[301]  C. Croft,et al.  Ulceration of the mouth, pharynx, and larynx in Crohn's disease of the intestine , 1972, The British journal of surgery.

[302]  S. Broitman,et al.  Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro , 1972, Gut.

[303]  I. Todd,et al.  Crohn's Disease of the Mouth , 1969, Proceedings of the Royal Society of Medicine.

[304]  B. Morson,et al.  Crohn's Disease (Regional Enteritis) of the Large Intestine and its Distinction from Ulcerative Colitis , 1960, Gut.

[305]  E. Pamer,et al.  Correction: Interbacterial mechanisms of colonization resistance and the strategies pathogens use to overcome them , 2019, Mucosal Immunology.

[306]  Julia L. Drewes,et al.  High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia , 2017, npj Biofilms and Microbiomes.

[307]  C. Roques,et al.  Role of Fusobacterium nucleatum in Periodontal Health and Disease , 2016 .

[308]  C. Fiocchi,et al.  Immunopathogenesis of IBD: current state of the art , 2016, Nature Reviews Gastroenterology &Hepatology.

[309]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[310]  J. Gorski,et al.  Cross-reactivity of T cells and its role in the immune system. , 2012, Critical reviews in immunology.

[311]  S. Iyer,et al.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. , 2012, Critical reviews in immunology.

[312]  D. Owczarek,et al.  Proinflammatory cytokines in the saliva of patients with active and non-active Crohn's disease. , 2012, Polskie Archiwum Medycyny Wewnetrznej.

[313]  Malfertheiner,et al.  World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. , 2010, Inflammatory bowel diseases.

[314]  J. Stockman Differentiating Ulcerative Colitis from Crohn Disease in Children and Young Adults: Report of a Working Group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America , 2009 .

[315]  R. Eliakim,et al.  Nutritional status and nutritional therapy in inflammatory bowel diseases. , 2009, World journal of gastroenterology.

[316]  W. Hop,et al.  Chemokine production by buccal epithelium as a distinctive feature of pediatric Crohn??s disease , 2006 .

[317]  E. Melzer,et al.  Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. , 2003, Oral diseases.

[318]  K. Geboes Histopathology of Crohn ’ s disease and ulcerative colitis , 2003 .

[319]  J. Potempa,et al.  Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. , 1997, Journal of periodontal research.

[320]  H. Smart,et al.  Crohn's disease in Jewish people--an epidemiological study in south-east Wales. , 1986, Digestion.

[321]  J. Zambon Actinobacillus actinomycetemcomitans in human periodontal disease. , 1985, Journal of clinical periodontology.

[322]  W. Ketterl [Periodontal diseases]. , 1971, Der Zahnarzt; Colloquium med. dent.

[323]  G PLACITELLI,et al.  [Ulcerative colitis]. , 1958, La Riforma medica.